Dosage and administration
ALWAYS PATCH TEST A SMALL AREA BEFORE FIRST APPLICATION. APPLY SPARINGLY TO AFFECTED AREAS ONCE OR TWICE DAILY AS NEEDED, AVOIDING THE EYE AREA. DRYNESS AND LIGHT PEELING MAY OCCUR DURING THE FIRST FEW WEEKS OF USAGE.
ALWAYS PATCH TEST A SMALL AREA BEFORE FIRST APPLICATION. APPLY SPARINGLY TO AFFECTED AREAS ONCE OR TWICE DAILY AS NEEDED, AVOIDING THE EYE AREA. DRYNESS AND LIGHT PEELING MAY OCCUR DURING THE FIRST FEW WEEKS OF USAGE.
BENZOYL PEROXIDE 10%
ACNE TREATMENT
HELPS REDUCE ACNE BREAKOUTS.
FOR EXTERNAL USE ONLY. DO NOT USE IF YOU ARE ALLERGIC OR SENSITIVE TO BENZOYL PEROXIDE. WHEN USING THIS PRODUCT AVOID CONTACT WITH EYES, LIPS AND MOUTH. IF CONTACT OCCURS, FLUSH THOROUGHLY WITH WATER. AVOID UNNECESSARY SUN EXPOSURE. MAY BLEACH FABRIC. MILD IRRITATION MAY BE REDUCED BY USING THE PRODUCT LESS FREQUENTLY OR IN A LOWER CONCENTRATION. DISCONTINUE USE, IF IRRITATION OCCURS AND CONSULT YOUR DOCTOR. USING OTHER TOPICAL ACNE MEDICATION AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN.
ALWAYS PATCH TEST A SMALL AREA BEFORE FIRST APPLICATION. APPLY SPARINGLY TO AFFECTED AREAS ONCE OR TWICE DAILY AS NEEDED, AVOIDING THE EYE AREA. DRYNESS AND LIGHT PEELING MAY OCCUR DURING THE FIRST FEW WEEKS OF USAGE.
WATER, SULFUR 3%, BUTYLENE GLYCOL, CARBOMER, POTASSIUM SORBATE, PHENOXYETHANOL, SODIUM BENZOATE, SODIUM HYDROXIDE.
KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70764-107-51 | 2025-12-31 | C162847 | 48780-1 | 2cef2736-8292-d83d-e063-dadaa90ab31f | CONTROL CORRECTION - CLEAR MED 10% (70764-107) |
| 70764-107-51 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8292-d83d-e063-dadaa90ab31f | CONTROL CORRECTION - CLEAR MED 10% (70764-107) |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70764-107-11 | CLEAR MED10% | 74 mL in 1 TUBE | LOTION | 74 | 8 | |
| 70764-107-51 | CLEAR MED10% | 1 in 1 BOX | LOTION | 1 | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70764-107 | 70764-107-11, 70764-107-51 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SULFUR | 70FD1KFU70 | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| CARBOMER COPOLYMER TYPE A | 71DD5V995L | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| BENZOYL PEROXIDE | W9WZN9A0GM | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLEAR MED 10% | BENZOYL PEROXIDE | CONTROL CORRECTIVE SKINCARE INC | 7acd1404-2af7-4ec4-b1e9-a905c9f823b8 | 2025-12-31 | Warnings | 70764-107-51 70764-107-11 70764-107 70764010751 70764010711 474ba495-afdc-f075-e063-6394a90a3637 7acd1404-2af7-4ec4-b1e9-a905c9f823b8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.